BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//TRUDEAU SOCIETY - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.trudeausociety.org
X-WR-CALDESC:Events for TRUDEAU SOCIETY
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20240612T120000
DTEND;TZID=America/Los_Angeles:20240612T130000
DTSTAMP:20260430T144627
CREATED:20240515T011310Z
LAST-MODIFIED:20240515T011822Z
UID:10000130-1718193600-1718197200@www.trudeausociety.org
SUMMARY:Cell Based Therapies for ARDS | Michael A. Matthay\, MD
DESCRIPTION:LOMA LINDA University in association with Breathe Southern California and Trudeau Society Present: Philip Gold\, M.D.Distinguished Scholar Lecture: Virtual Online\nCell Based Therapies for ARDS\nMichael Matthay\, MD\, Director of the Critical Care Medicine ‐ University of California San Francisco \nEEDS LINK TO JOIN VIRTUALLY\nAbout The Speaker\nMichael A. Matthay\, MD is a Professor of Medicine and Anesthesia at the University of California at San Francisco and a Senior Associate at the Cardiovascular Research Institute. He is Associate Director of the Critical Care Medicine Training in the Department of Medicine and Associate Director of the Intensive Care Unit.  He received his AB from Harvard University and his MD from the University of Pennsylvania School of Medicine. Dr. Matthay received clinical training in Internal Medicine at the University of Colorado from and in Pulmonary and Critical Care Medicine from the University of California at San Francisco. He also received research training from the Cardiovascular Physiology Laboratory\, University of Colorado and the Cardiovascular Research Institute. \nResearch Interests:  Dr. Matthay’s basic research is focused on active ion and water transport mechanisms that account for the resolution of pulmonary edema as well as mechanisms that account for alveolar epithelial repair after acute lung injury.  The studies are carried out in several in vivo and in vitro models.  Dr. Matthay’s clinical research is focused on the mechanisms that account for the pathogenesis and resolution of clinical acute lung injury and pulmonary edema.  His laboratory has approximately 5-6 fellows with a mixture of PhD and MD fellows with weekly research conferences that include both basic and clinical research topics.  He also has directed several phase 2 and 3 clinical trials supported by the NIH including ARDS Net and the PETAL networks and been an Investigator for several trials in COVID-19 and sepsis.  He has a major time commitment to training residents\, fellows and junior faculty for a career in academic medicine. \nLearning Objectives:\nAt the conclusion of this activity\, participants should be able to:  \n\nDiscuss the mechanisms by which mesenchymal stromal cells can reduce lung injury in pre‐clinical studies\nReview results of clinical trials for classical ARDS and COVID‐19 ARDS\nConsider the steps forward to find the treatment responsive sub‐groups of ARDS patients for mesenchymal cells or mesenchymal cell‐derived treatments \n\nAccreditation Statement:\nThe Loma Linda University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education ﴾ACCME﴿ to provide continuing medical education for physicians.  \nDisclosure Statement\nThis program has been planned and implemented in accordance with ACCME essentials and standards. The Loma Linda University School of Medicine Office of Continuing Medical Education relies on its CME faculty to provide program content that is free of commercial bias. Therefore\, in accordance with ACCME standards\, any faculty and/or provider industry relationships will be disclosed and resolved.  \nCredit Designation:\nThe Loma Linda University School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. \nEEDS LINK TO JOIN VIRTUALLY
URL:https://www.trudeausociety.org/event/cell-based-therapies-for-ards-michael-a-matthay-md/
LOCATION:CA
ORGANIZER;CN="Trudeau Society & Breathe Southern California":MAILTO:MCarmona@breathesocal.org
END:VEVENT
END:VCALENDAR